Brown, Lisle/Cummings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.11K Hold
36
– – ﹤0.01% 787
2026
Q2
$2.42K Buy
+36
New +$2.4K ﹤0.01% 823
2025
Q2
– Sell
-3
Closed -$205 – 783
2025
Q1
$205 Buy
+3
New +$245 ﹤0.01% 778

Other funds holding DXCM

Brown, Lisle/Cummings's DXCM Position: Q3 2026 in Review

Brown, Lisle/Cummings held its DexCom (DXCM) position steady in Q3 2026 at 36 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Brown, Lisle/Cummings first reported a position in DXCM in Q1 2025 and has held it in 3 quarters since. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Brown, Lisle/Cummings held 36 shares of DexCom worth $3.11K as of Q3 2026.
  • Brown, Lisle/Cummings left its DexCom share count unchanged in Q3 2026.
  • DexCom made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q3 2026, its #787 holding.
  • Brown, Lisle/Cummings first reported a position in DexCom in Q1 2025 and has held it in 3 quarters since.
  • 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q3 2026, filed 16 Oct 2026.